Protamine sulfate is an argininerich polypeptide used as the clinical antidote to heparin and as a functional excipient in selected parenteral and combination products. Its mechanism of action is electrostatic binding to negatively charged heparin, forming stable complexes that rapidly neutralise anticoagulant activity. Clinically, protamine is employed primarily in cardiovascular and surgical settings, including cardiopulmonary bypass and interventional cardiology, and during haemodialysis; it has also been investigated as a cationic component in delivery systems and in controlledrelease formulations.
Manufacturing and formulation present significant technical challenges. Protamine is polydisperse, sensitive to pH, ionic strength and temperature, and is prone to aggregation and batchtobatch variability in potency. Finished forms require robust control of degradation pathways, validated protection against bacterial endotoxin and confirmed retention of biological activity. Lyophilisation is commonly used to improve stability and shelf life for parenteral presentations, while validated endotoxin and sterility controls are mandatory.
Quality control must rely on orthogonal, validated analytics and process controls. Recommended controls include a stabilityindicating HPLC/UPLC assay for quantitative total content; LCMS peptide mapping for identity and impurity characterisation; chromatographic methods for related substances and oxidation products; a validated potency bioassay for heparin neutralisation with traceable calibration; and BET methodsuitability studies to exclude matrix interference. Process validation, environmental monitoring for aseptic filling, containerclosure compatibility and a structured stabilitymonitoring programme are integral to the finishedproduct control strategy.
MediPharm positions itself as an integrated development and GMP platform that delivers method transfer and validation reports, clinicalgrade GMP batches, validated BET and sterility assurance, comprehensive stability datasets and regulatory dossier preparation for EU submissions.